Cargando…
Sunitinib-Induced Acute Interstitial Nephritis in a Thrombocytopenic Renal Cell Cancer Patient
Sunitinib, a multitargeted tyrosine kinase inhibitor (TKI), is currently the standard of care for patients with metastatic renal cell carcinoma. Renal adverse events associated with sunitinib include proteinuria, renal insufficiency secondary to focal segmental glomerulosclerosis (FSGS), and thrombo...
Autores principales: | Azar, Ibrahim, Esfandiarifard, Saghi, Sinai, Pedram, Wazir, Ali, Foulke, Llewellyn, Mehdi, Syed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735624/ https://www.ncbi.nlm.nih.gov/pubmed/29359059 http://dx.doi.org/10.1155/2017/6328204 |
Ejemplares similares
-
The impact of primary tumor sidedness on survival in early‐onset colorectal cancer by stage: A National Veterans Affairs retrospective analysis
por: Azar, Ibrahim, et al.
Publicado: (2021) -
Drug-induced immune thrombocytopenic purpura secondary to sunitinib
por: Trinkaus, M., et al.
Publicado: (2008) -
Naproxen Induced Acute Interstitial Nephritis with Renal Cortical Necrosis
por: Jane, Christine M., et al.
Publicado: (2020) -
ACUTE INTERSTITIAL NEPHRITIS
por: Councilman, W. T.
Publicado: (1898) -
Rosuvastatin-Induced Acute Interstitial Nephritis
por: Londrino, Francesco, et al.
Publicado: (2013)